Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 10;23(3):67.
doi: 10.1208/s12248-021-00591-z.

There is Only One Valid Definition of Clearance: Critical Examination of Clearance Concepts Reveals the Potential for Errors in Clinical Drug Dosing Decisions

Affiliations

There is Only One Valid Definition of Clearance: Critical Examination of Clearance Concepts Reveals the Potential for Errors in Clinical Drug Dosing Decisions

Leslie Z Benet et al. AAPS J. .

Abstract

Drug dosing decisions in clinical medicine and in introducing a drug to market for the past 60 years are based on the pharmacokinetic/clinical pharmacology concept of clearance. We used chemical reaction engineering models to demonstrate the limitations of presently employed clearance measurements based upon systemic blood concentration in reflecting organ clearance. The belief for the last 49 years that in vivo clearance is independent of the mechanistic model for organ clearance is incorrect. There is only one valid definition of clearance. Defining organ clearance solely on the basis of systemic blood concentrations can lead to drug dosing errors when drug effect sites reside either in an eliminating organ exhibiting incremental clearance or in a non-eliminating organ where intraorgan concentration is governed by transporter actions. Attempts to predict clearance are presently hampered by the lack of recognition that what we are trying to predict is a well-stirred model clearance.

Keywords: chemical reaction engineering models; clearance; well-stirred model.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Chemical engineering reaction (pharmacokinetic) models at steady state (logarithmic concentration on Y-axis)

Comment in

References

    1. Rowland M. Influence of route of administration on drug availability. J Pharm Sci. 1972;61:70–74. doi: 10.1002/jps.2600610111. - DOI - PubMed
    1. Pang KS, Rowland M. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liver in situ preparation. J Pharmacokinet Biopharm. 1977;5:655–680. doi: 10.1007/BF01059689. - DOI - PubMed
    1. Page KM. Validation of early human dose prediction: a key metric for compound progression in drug discovery. Mol Pharmaceut. 2015;13:609–620. doi: 10.1021/acs.molpharmaceut.5b00840. - DOI - PubMed
    1. Maurer TS, Smith D, Beaumont K, Di L. Dose predictions for drug design. J Med Chem. 2020;63:6423–6435. doi: 10.1021/acs.jmedchem.9b01365. - DOI - PubMed
    1. Bowman CM, Benet LZ. Hepatic clearance prediction from in vitro–in vivo extrapolation and the Biopharmaceutics Drug Disposition Classification System. Drug Metab Dispos. 2016;44:1731–1735. doi: 10.1124/dmd.116.071514. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances